| News Release
Symantec Launches Transition Assistance for Pressured Dr. Solomon's Customers
Cupertino, Calif --September 14, 1998-- Symantec Corporation (Nasdaq:
SYMC) has launched a specialist transition service for Dr Solomon's
users that are being pressurized by Network Associates (Nasdaq: NETA)
to transition to an untested antivirus product.
Symantec Transition Services has been set up to provide bespoke
transition assistance for companies and individual end-users. Hotline
numbers provide direct access to transition specialists that can
provide immediate information and quick access to services such as
free technical support, free software to uninstall Dr Solomon's or
Network Associates antivirus products and install Norton AntiVirus,
and for qualifying companies, specialized consultancy and free
product.
Dr Solomon's was about to launch version 8.0 of its AntiVirus Toolkit
product when Network Associates announced its acquisition. In June, in
a statement on Dr Solomon's web site, Network Associates said it
wanted to alleviate customers concerns by telling them that AntiVirus
Toolkit was expected to ship on schedule this Fall. However, the
company has now told customers they will instead have to upgrade to a
totally new product in October which it says combines the two
companies' technology.
"It takes three months to fully test a new product, let alone one that
combines two completely different technologies. If Network Associates
is telling the truth about an October launch for a combined product
they are asking customers to move to a version 1.0 product that they
will not have had enough time to fully test," says Enrique Salem, vice
president of Symantec's Security and Assistance Business Unit.
"Network Associates is afraid of losing customers to competitors and
is rushing through an untested product simply to get customers locked
into a contract. Companies are being misled into thinking they will be
using finished product when in fact it will be the customers who are
doing the final testing.
"Aside from the danger to customers of virus infection from using an
untested product, customers will have little option but to go through
subsequent transition phases once the technology integration has been
carried out properly. Putting the security of their customers networks
at risk in order to get them signed up on a contract is wrong."
The aim of Symantec Transition Services, Salem adds, is to assist Dr
Solomon's customers who feel they are being railroaded by Network
Associates into making decisions about their corporate network
security that are more beneficial to Network Associates than to
themselves.
Symantec and IBM announced an alliance in May in which IBM assigned
its antivirus customer base to Symantec. Already more than 1,500
companies that were using IBM AntiVirus have committed to
transitioning to Symantec.
"Through our on-going experience of transitioning IBM's customers, we
have developed a deep understanding of the issues that companies face
when moving from one antivirus solution to another and refined a very
smooth and efficient transition process. Symantec Transition Services
will extend that experience and knowledge to Dr Solomon's customers
and Network Associates customers too for that matter," says Salem.
The Symantec Transition Services hotline number is: 1-800-734-2659.
About Symantec
Symantec is the world leader in utility software for business and personal computing.
Symantec products and solutions help make users productive and keep their computers
safe and reliable anywhere and anytime. Symantec offers a broad range of solutions
and is acclaimed as a leader in both customer satisfaction and product brand
recognition. Symantec is traded on Nasdaq under the symbol SYMC. More information
on the company and its products can be obtained at www.symantec.com.
NOTE TO EDITORS: If you would like additional information on Symantec Corporation and its products,
view the Symantec Press Center at www.symantec.com/PressCenter/ on Symantec's Website.
Brands and products referenced herein are the trademarks or registered trademarks of their
respective holders. All prices noted are in US dollars and are valid only in the United States.
|